Estrogen as therapy for breast cancer

Por Ingle, James N
Publicado em 2002

Introduction to clinical research sessions

Por Ingle, James N
Publicado em 2007

Oxford Overview

Por Ingle, James N
Publicado em 2007

Introduction to sessions on 'Endocrine therapy: where have we come from, where are we at and where are we going to?'

Por Ingle, James N
Publicado em 2008

Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer

Por Ingle, James N
Publicado em 2008

Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: going beyond associations

Por Ingle, James N
Publicado em 2010

Pharmacogenomics of endocrine therapy in breast cancer

Por Ingle, James N
Publicado em 2013

Introduction to session on undue and disproportionate influences

Por Ingle, James N, Miller, William R
Publicado em 2010

Two-Phase Designs to Follow-Up Genome-Wide Association Signals With DNA Resequencing Studies

Por Schaid, Daniel J., Jenkins, Gregory D., Ingle, James N., Weinshilboum, Richard M.
Publicado em 2013

Functional role of KLF10 in multiple disease processes

Por Subramaniam, Malayannan, Hawse, John R., Rajamannan, Nalini M., Ingle, James N., Spelsberg, Thomas C.
Publicado em 2010

Centrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarity

Por Lingle, Wilma L., Lutz, Ward H., Ingle, James N., Maihle, Nita J., Salisbury, Jeffrey L.
Publicado em 1998

TGFβ/TNFα-Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype

Por Asiedu, Michael K., Ingle, James N., Behrens, Marshall D., Radisky, Derek C., Knutson, Keith L.
Publicado em 2011

Urine Biomarkers of Risk in the Molecular Etiology of Breast Cancer

Por Gaikwad, Nilesh W., Yang, Li, Pruthi, Sandhya, Ingle, James N., Sandhu, Nicole, Rogan, Eleanor G., Cavalieri, Ercole L.
Publicado em 2009

Re: Concordance Between CYP2D6 Genotypes Obtained From Tumor-Derived and Germline DNA

Por Goetz, Matthew P., Brauch, Hiltrud, Ratain, Mark J., Cox, Nancy J., Nakamura, Yusuke, Weinshilboum, Richard, Ingle, James N.
Publicado no J Natl Cancer Inst (2014)

Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters

Por Brauch, Hiltrud, Schroth, Werner, Goetz, Matthew P., Mürdter, Thomas E., Winter, Stefan, Ingle, James N., Schwab, Matthias, Eichelbaum, Michel
Publicado em 2013

AXL induces epithelial to mesenchymal transition and regulates the function of breast cancer stem cells

Por Asiedu, Michael K., Beauchamp-Perez, Francis D., Ingle, James N., Behrens, Marshall D., Radisky, Derek C., Knutson, Keith L.
Publicado em 2013

Loss of Immunoreactivity for Human Calmodulin-Like Protein is an Early Event in Breast Cancer Development

Por Rogers, Michael S, Foley, Margaret A, Crotty, Thomas B, Hartmann, Lynn C, Ingle, James N, Roche, Patrick C, Strehler, Emanuel E
Publicado em 1999

Evaluation of the Aromatase Inhibition Potential of Freeze-Dried Grape Powder

Por Allen, Summer V., Pruthi, Sandhya, Suman, Vera J., Hoskin, Tanya L., Vachon, Celine M., Ingle, James N., Olson, Janet E.
Publicado no J Diet Suppl (2014)

The molecular etiology of breast cancer: Evidence from biomarkers of risk

Por Gaikwad, Nilesh W., Yang, Li, Muti, Paola, Meza, Jane L., Pruthi, Sandhya, Ingle, James N., Rogan, Eleanor G., Cavalieri, Ercole L.
Publicado no Int J Cancer (2008)

CYP2D6 genotype and tamoxifen response

Por Rae, James M, Goetz, Matthew P, Hayes, Daniel F, Ingle, James N, Li, Lang, Storniolo, Anna Maria, Stearns, Vered, Flockhart, David A
Publicado em 2005